Cell and Gene Outsourcing

  1. Accelerated Delivery Of Manufacturing Capacity 5/14/2026

    When demand spikes unexpectedly, standardized facility design and aligned equipment strategies can dramatically shorten expansion timelines. See how to reduce uncertainty across procurement.

  2. Viral Vector Manufacturing Simplified: A Sponsor's Guide To Smarter CDMO Partnerships 5/13/2026

    Smarter viral vector manufacturing starts with early alignment, realistic scaling, and collaboration. Strategy and transparency reduce risk, control costs, and keep timelines on patients.

  3. Unlocking Durable Allogeneic Cell Therapy 5/13/2026

    Advances in genome engineering and immune evasion are enabling scalable, durable allogeneic cell therapies, overcoming rejection challenges and expanding potential treatments across diverse diseases.

  4. How To Effectively Manage Local Affiliate Pharmacovigilance Outsourcing 5/12/2026

    Managing PV across dozens of markets strains even experienced safety teams. Learn about a framework that helps you maintain compliance, reduce risk, and scale confidently into new markets.

  5. Mid-Sized Pharma Optimizes Local Affiliate Safety Operations 5/12/2026

    Managing local affiliate PV strains any team. See how a mid-sized biopharma standardized ICSR processing across 94 countries, improved compliance tracking, and achieved centralized oversight.

  6. Eliminating The Black Box In Gene Therapy Manufacturing 5/12/2026

    Integrated real-time visibility transforms outsourced gene therapy manufacturing from fragmented, reactive coordination into proactive execution, enabling faster decisions, stronger alignment, improved accountability, and timeline confidence.

  7. Antibody Manufacturing Powered By Proven Biomanufacturing Excellence 5/12/2026

    A practical guide to resilient antibody manufacturing — scalable mammalian platforms, downstream efficiency, viral safety, and analytics — plus proven practices to reduce scale‑up risk and ensure consistent GMP supply.

  8. Design Scalable Downstream Processes With Practical Strategies 5/11/2026

    Downstream purification is becoming more complex as new modalities enter development. Learn how advanced analytics and chromatography strategies can support scalable, confident process development.

  9. Can A Biotech Create A CDMO Market? 5/11/2026

    Can a biotech create a CDMO market? GeoVax, an infectious disease/oncology biotech, may have just done so. David Dodd, CEO, believes we should all concentrate more on whether the outsourcing model can align with evolving technology platforms. Both sponsors and CDMOs may need to change things up.

  10. The Growing Strategic Importance Of CDMOs In CGT 5/8/2026

    Discover how advanced manufacturing platforms, integrated analytics, and accelerated development strategies are helping overcome the scalability, supply chain, and operational challenges.